William R. Jellison - 20 Jun 2025 Form 4 Insider Report for Anika Therapeutics, Inc. (ANIK)

Reporting relationship: Director
Issuer ticker: ANIK
Reported as of: 20 Jun 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 24 Jun 2025, 17:12:27 UTC
Prior SEC filing: 02 May 2025
Next SEC filing: 02 Jul 2025
Source filing: View source filing
Reporting owner signature: /s/ William R. Jellison

Key filing fact

William R. Jellison filed Form 4 for Anika Therapeutics, Inc. (ANIK) on 24 Jun 2025.

Key facts

This page summarizes William R. Jellison's Form 4 filing for Anika Therapeutics, Inc. (ANIK).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 24 Jun 2025, 17:12.

Change

Previous filing in this sequence was filed on 02 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001189883 Primary reporting owner

Jellison William R

Relationship: Director
Address: 32 WIGGINS AVENUE, BEDFORD
Signature: /s/ William R. Jellison
Signature date: 24 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ANIK transaction

Common Stock

Award

Transaction value: $0
Shares: +14,164
Change %: +227%
Price: $0.000000
Shares after: 20,403
Date: 20 Jun 2025
Ownership: Direct
Footnotes: F1

ANIK holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 2,700
Date: 20 Jun 2025
Ownership: Revocable Trust
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These shares represent restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2026 annual meeting of the Company's stockholders or June 20, 2026.

Footnote F2

Consists of shares transferred by Mr. Jellison to the Amended and Restated William R. Jellison Trust dated July 3, 2018, of which Mr. Jellison is a beneficiary and trustee.